CD4+ memory T-cells are present within the microenvironment of most human non-small cell lung tumors and appear quiescent and non-responsive to the tumor. We question here how these cells are maintained within the tumor for prolonged periods, and how they may be activated in situ to kill tumors. The implantation of non-disrupted human lung tumor biopsy tissues into the subcutis of SCID mice, results in the establishment of xenografts with structurally and functionally intact tumor microenvironments. By monitoring changes in the histology, gene expression patterns, cell depletion analysis and the use of function blocking antibodies, it has been established that exogenous IL-12 mobilizes effector memory CD4+ T cells (TEM) to kill tumor cells in situ by indirect mechanisms that are dependent upon IFN-y. Using this human mouse chimeric model, we will first test the hypothesis that the sustained presence of the CD4+ TEM cells within human tumor microenvironments is dependent upon tumor-associated stromal fibroblasts and plasmacytoid dendritic cells that release Type I interferons and inhibit apoptosis of activated T cells.
In Aim 2, the ability of chemokines and their receptors to influence CD4+ TEM cells derived from the tumor microenvironment to home to and eradicate IL-12 treated tumor xenografts will be compared to central memory T cells (CD4+ TCM) derived from patients' tumor draining lymph nodes. In the final Aims, two specific issues regarding the IL-12 functional activation of memory T cells are addressed.
Aim 3 will establish in the tumor microenvironment whether one or more B7 family co-stimulatory (or negative regulatory) molecules expressed by dendritic cells, stromal cells or tumor cells regulate the anti-tumor response that is orchestrated by IL-12 activated TEM cells. In the final Aim, tumor-associated memory T cell responsiveness to T cell receptor stimuli, the intracellular events associated with this stimulation, and the ability of IL-12 to alter the responsiveness will be determined and compared to central memory and na?ve T cells. It is expected that the knowledge generated here with respect to the survival, migration and activation potential of tumor-associated memory T cells will lead to the design of improved immunotherapeutic approaches that can harness the anti-tumor activity of the memory T cells and enhance their activity by targeting and modulating other inflammatory leukocytes and stromal cells in the tumor microenvironment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA108970-02
Application #
7024536
Study Section
Transplantation, Tolerance, and Tumor Immunology (TTT)
Program Officer
Mccarthy, Susan A
Project Start
2005-04-01
Project End
2010-02-28
Budget Start
2006-04-01
Budget End
2007-02-28
Support Year
2
Fiscal Year
2006
Total Cost
$299,654
Indirect Cost
Name
State University of New York at Buffalo
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Shenoy, Gautam N; Loyall, Jenni; Berenson, Charles S et al. (2018) Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments. J Immunol 201:3750-3758
Shenoy, Gautam N; Loyall, Jenni; Maguire, Orla et al. (2018) Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses. Cancer Immunol Res 6:236-247
Kelleher Jr, Raymond J; Balu-Iyer, Sathy; Loyall, Jenni et al. (2015) Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade. Cancer Immunol Res 3:1269-78
Fathallah, Anas M; Bankert, Richard B; Balu-Iyer, Sathy V (2013) Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspective. AAPS J 15:897-900
Gaitonde, Puneet; Ramakrishnan, Radha; Chin, Jamie et al. (2013) Exposure to factor VIII protein in the presence of phosphatidylserine induces hypo-responsiveness toward factor VIII challenge in hemophilia A mice. J Biol Chem 288:17051-6
Simpson-Abelson, Michelle R; Loyall, Jenni L; Lehman, Heather K et al. (2013) Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-?B and NFAT signaling in tumor-associated T cells. Cancer Immun 13:14
Yokota, Sandra J; Facciponte, John G; Kelleher Jr, Raymond J et al. (2013) Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model. Cancer Immun 13:11
Bernstein, Joel M; Lehman, Heather; Lis, Maciej et al. (2012) Humanized mouse model used to monitor MUC gene expression in nasal polyps and to preclinically evaluate the efficacy of montelukast in reducing mucus production. Ann Otol Rhinol Laryngol 121:307-16
Lehman, Heather K; Simpson-Abelson, Michelle R; Conway Jr, Thomas F et al. (2012) Memory T cells in the chronic inflammatory microenvironment of nasal polyposis are hyporesponsive to signaling through the T cell receptor. J Assoc Res Otolaryngol 13:423-35
Bankert, Richard B; Balu-Iyer, Sathy V; Odunsi, Kunle et al. (2011) Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis. PLoS One 6:e24420

Showing the most recent 10 out of 17 publications